Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
The current Halozyme Therapeutics(HALO) stock price is $62.88, with a market capitalization of 7.4B. The stock trades at a price-to-earnings (P/E) ratio of 13.59.
During the trading session on 2025-12-05, Halozyme Therapeutics(HALO) shares reached a daily high of $66.00 and a low of $61.70. At a current price of $62.88, the stock is +1.9% higher than the low and still -4.7% under the high.
Trading volume for Halozyme Therapeutics(HALO) stock has reached 4.21M, versus its average volume of 2.5M.
The stock's 52-week range extends from a low of $46.26 to a high of $79.50.
The stock's 52-week range extends from a low of $46.26 to a high of $79.50.
HALO News
The ruling applies only to the subcutaneous formulation of the Rahway, N.J., company’s treatment, rather than the intravenous formulation, which Halozyme said i...
Halozyme Therapeutics (HALO) announced that a German court has granted its request for a preliminary injunction ordering Merck (MRK) to refrain from distributin...
In recent months, Halozyme Therapeutics completed its US$750,000,000 acquisition of Elektrofi, expanded its ENHANZE-powered partnerships through a new collabora...
